FindTrial
Sign In

A multicenter, real-world study to evaluate the early diagnosis and specific mortality of prostate cancer patients with PSA screening versus those with routine clinical care in Chinese population

A multicenter, real-world study to evaluate the early diagnosis and specific mortality of prostate cancer patients with PSA screening versus those with routine clinical care in Chinese population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104154
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-06-12
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Screening group:None
Non-screening group:None

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients are eligible to be included in the study only if they met all the following criteria: 1. Male, aged >=50 years. 2. Newly diagnosed with prostate cancer (PC) between August 1, 2019, and April 1, 2025. 3. Identified as residents of Guangdong Province, as indicated by the place of residence on their national identification card.

Exclusion criteria

Exclusion criteria: Patients are excluded if any of the following factors were present: 1. History of prostate cancer diagnosis prior to August 1, 2019. 2. Non-residents of Guangdong Province (i.e., individuals without Guangdong household registration).

Design outcomes

Primary

MeasureTime frame
prostate cancer-specific mortality;the proportion of localized prostate cancer(T1/2N0M0);—

Secondary

MeasureTime frame
the proportion of clinically significant prostate cancer (ISUP grade=2);the proportion of metastatic cases (M1-stage);healthcare resource utilization;—

Countries

China

Contacts

Public ContactGuohua Zeng

The First Affiliated Hospital of Guangzhou Medical University

gzgyzgh@vip.sina.com+86 138 0291 6676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026